Deaths from Uterine Cancer
Deaths from Uterine Cancer: 6,468 deaths reported in USA 1999 (NVSR Sep 2001)
Deaths from types of Uterine Cancer: for details see deaths from types of Uterine Cancer analysis; summary of available deaths by type data:
- Endometrial Carcinoma: estimated 6,600 deaths in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
- Cervical cancer: approximately 4,600 women will die in 2001 (DSTD)
Death rate extrapolations for USA for Uterine Cancer:
6,468 per year,
539 per month,
124 per week,
17 per day,
0 per hour,
0 per minute,
0 per second.
Note: this automatic extrapolation calculation uses the deaths statistic: 6,468 deaths reported in USA 1999 (NVSR Sep 2001)
Survival rate statistics for Uterine Cancer:
The following are statistics from various sources
about the survival rate for Uterine Cancer:
- 86% of white people survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
- 60% of African American people survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
- 84% survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
- 83.2% of people with uterine corpus cancer survive after 5 years in the US 1983-90 (SEER)
- 5-year survival rate for black women with corpus and uterus cancer is 55.2% in the US 1983-90 (SEER)
- 5-year survival rate for white women with corpus and uterus cancer is 84.9% in the US 1983-90 (SEER)
- 5-year survival rate for women with corpus and uterus cancer is 83.2% in the US 1983-90 (SEER)
- 1-year survival rate for women aged 15-99 with uterine cancer is 85.2% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 15-99 with uterine cancer is 70.6% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 15-39 with uterine cancer is 90% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 15-39 with uterine cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 40-49 with uterine cancer is 93% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 40-49 with uterine cancer is 85% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 50-59 with uterine cancer is 93% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 50-59 with uterine cancer is 83% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 60-69 with uterine cancer is 89% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 60-69 with uterine cancer is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 70-79 with uterine cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 70-79 with uterine cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 1-year survival rate for women aged 80-99 with uterine cancer is 64% in England and Wales 1991-95 (Cancer Survival, National Statistics)
- 5-year survival rate for women aged 80-99 with uterine cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
Average life years lost from Uterine Cancer: 15.3 years for corpus/uterus NOS, not including cervix cancer (SEER)1
Death statistics for Uterine Cancer:
The following are statistics from various sources
about deaths and Uterine Cancer:
- 7,090 estimated deaths for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
- 7,090 estimated female deaths for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
- 3 per 100,000 deaths in women from uterine cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
- 700 deaths in women from uterine cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
- Mortality rate statistics for deaths from uterine cancer in various countries:
- 2.0 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.6 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.8 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.9 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.2 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.8 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.4 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 0.4 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.5 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.9 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.0 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.4 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.4 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.9 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.5 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.1 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.1 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.1 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.1 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.5 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.8 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.2 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.4 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.9 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.3 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.9 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.0 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 0.2 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.5 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.2 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.2 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.0 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.9 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.3 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.2 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.2 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.6 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 5.2 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.4 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.4 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 2.0 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 4.3 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.4 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 1.7 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- 3.7 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
- Uterine cancer caused 261 female deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
- Uterine cancer accounted for 1.7% of female cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
- Uterine cancer accounted for 2.5 female deaths per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
Deaths from Uterine Cancer: medical news summaries:
The following medical news items
are relevant to death from Uterine Cancer:
Premium articles about Death:
This section lists our premium articles on topics related to
death. These are original authored articles on topics of great interest:
- Deaths Overview
- Deaths rates by age:
newborn,
infant,
child,
teens,
20s,
30s,
40s,
50s,
60s,
70s,
80s,
90s,
100s
- What Will I Die From?
- Conditions by Deaths
- More premium medical articles ...
A diagnosis of breast cancer usually leads to some form of surgery. Afterward, various therapies help guard against spread or recurrence of disease....
For many women, any gynecologic procedure is an unattractive prospect, and something with a name like "hysteroscopy" sounds downright frightening. In...
As many as 20 to 50 percent of all women develop fibroids. These benign muscle tumors usually grow in the uterus, and can cause pain, and in some...
As many as 20 to 50 percent of all women develop fibroids. These benign muscle tumors usually grow in the uterus, and can cause pain, and in some...
See full list of 6 related videos
» Next page: Death Statistics for Types of Uterine Cancer
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: